Health Breaking News: Link 292

Health Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

Health Breaking News: Link 292


Global Health Development Value Frameworks: Are We Calculating Well and Wisely? 

Jean Tirole Connects the Dots: Lessons from Modern Economics for Global Health Procurement 

The Myth Behind Health And Trade Agreements – Q&A With Othoman Mellouk 

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa 

It’s Time To Rethink The Anatomy Of Physician Behavior 

Poor countries subsidise the NHS by training doctors – compensate them 

International Conference: Development Policies and Practices in the Democratic Republic of Congo 5 – 7 November 2018 – Centre Bilembo, Kinshasa-Gombe 

MSF Challenges Gilead Hepatitis C Patent In China 

Chilean Cámara de Diputados Overwhelmingly Asks the Ministry of Health to Proceed with Compulsory Licenses for HCV drugs 

South Africa: A new revolution in TB treatment as the injection falls 

Searching for a change: The need for increased support for public health and research on fungal diseases 

ICD-11: Classifying disease to map the way we live and die 

The association of lifetime alcohol use with mortality and cancer risk in older adults: A cohort study  

Human Rights Reader 452 

US exit from UN Human Rights Council widens gaps for human rights NGOs, experts warn 

Master Salute Globale e Migrazioni Bologna 2-6 luglio 2018 

Countries are Using Domestic Laws to Criminalize Health Care 

“Ready to Make Our Mark.” An Immigrant Group Becomes a Powerful Force in Philanthropy 

The Global Humanitarian Assistance 2018 report is out today – here are six top findings 

UNPO: Jul 11, 2018 European Parliament Conference: 2018 Ethiopia – Ways Toward Politically-Inclusive Democracy 

Who is talking about the UN Sustainable Development Goals? 

Almost half of Indians out of drinking water by 2030, 600 million facing shortages – study 

Ukraine Puts Water Strategy High on Development Agenda  

6 things you didn’t know about your food shopping 

We will not go back on women’s health and rights 

A Partnership Making the Case for Supporting Grassroots Climate Work 


HEAL’s vision on Europe leading the way to a non-toxic environment 

Six EU governments finally face legal action over air pollution 

Q&A: Adapt to climate by packaging local results into policy 

Health Breaking News: Link 291

Health Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

Health Breaking News: Link 291


How Democracies Die and Economies Grow 

Greece: SDGs a Way to End Economic Crisis? 

Supporting Small-Scale Cross-Border Traders Across Africa 

Songs, radio shows, and door-to-door visits: how community awareness is helping defeat Ebola in Congo 

At one-month mark in Ebola outbreak, the focus shifts to remote areas 

The latest Ebola outbreak: what has changed in the international and U.S. response since 2014? 

Hepatitis experts call to action to secure financing viral hepatitis C eradication 

Mother-to-Child Transmission of HIV in Kyrgyzstan is Minimal 

Ensuring no one is left behind: Urgent action required to address implementation challenges for NTD control and elimination 

First new treatment for river blindness approved by U.S. FDA in 20 years 

Angola: Over One Million Cases of Malaria in First Half in Angola 

WHO certifies Paraguay malaria-free 

1.45 Million Children’s Lives Saved by HiB and Pneumococcal Vaccines Since 2000 

World Day Against Child Labour – 12 June 2018: Generation Safe & Healthy 

Service readiness for inpatient care of small and sick newborns: what do we need and what can we measure now? 

Human Rights Reader 451 

Video: Indigenous Peoples Seek To Be Involved In World Trade Organization To Defend Rights 

‘Challenges and Solutions for the Latinx Population to Effectively Participate in Clinical Trials’ by Karen Mancera Cuevas 

UNPO Speak Out 2018 

Public Support for Needle Exchange Programs, Safe Injection Sites Remains Low in U.S. 

Women entrepreneurs ‘a vast untapped resource’, say development policy-makers 

To Change Africa’s Path, We Need to Support Rural Girls from Day One 

What should countries in the Global South do about Global Kidney Exchange (GKE) programs? 

Deal slashes drug price of 3 in 1 pill for people living with HIV 

How to find a reputable API supplier 

Liberia’s leader Weah looks abroad for help tackling poverty 

Hunger surges amid deadly conflicts, poor weather conditions in many countries – UN agriculture agency 

Great Green Wall Brings Hope, Greener Pastures to Africa’s Sahel 

Climate change: Pope urges action on clean energy 

Ocean Conservation Is an Untapped Strategy for Fighting Climate Change 

A Bigger Tent: Where Climate Philanthropy Needs to Go Next 

Decision time for EU’s 2030 clean energy laws 









Health Breaking News: Link 290

Health Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

Health Breaking News: Link 290


Industrial competitiveness as ‘societal challenge’? Ensuring accountability and societal impact in Horizon Europe CSO reaction to the Commission’s FP9 proposal 

European Development Days: Investing in women and girls 

Real change for girls requires more than words at G7 summit 

Publication: Women’s Rights and Trade – Time for a radical shift 

Health and vaccine research set to lose out from new EU research budget 

The Medicines Patent Pool Presents New Five-Year Strategy For Improving Access To Priority Treatments In Developing Countries 

Balancing Affordability And Access: Lessons From New Cholesterol-Lowering Drugs 

Dept. of Existential Threats: Who’s Worried About Superbugs?  

COBATEST Network is Looking for the New Members in EECA 

More political attention, research solutions needed for TB, experts say 

BRICS countries pulling up their socks for the upcoming UN high level meeting on TB at the 71st World Health Assembly 

THE DISEASE THAT STRIKES BACK Could a form of leishmaniasis challenge elimination efforts in India? 

Ebola treatments approved for compassionate use in current outbreak 

As Aid Workers Move to the Heart of Congo’s Ebola Outbreak, ‘Everything Gets More Complicated’ 

Aid worker invents vest with built-in chemicals protection 

A genetically modified organism could end malaria and save millions of lives — if we decide to use it 

Is rising inequality responsible for greater stress, anxiety and mental illness? 

Human Rights Reader 450 

WHO: World Blood Donor Day 14 June 2018 


UNPO Newsletter May 2018 edition 

UN agencies and Myanmar ink agreement, setting stage for Rohingya return 

Turning ‘Leave No One Behind’ from promise to reality: Kevin Watkins on the Power of Convergence  

The importance of preventing delays during health emergencies 

Wasted Health Spending: Who’s Picking Up The Tab? 

A year after Trump’s withdrawal from the Paris Agreement  

More world leaders invited to G7 Summit for oceans protection 

Plastic bans among ‘most effective’ ways to beat pollution, says UN 

WWF applauds European Commission plastics proposal 

Five things you can do to end plastic pollution 


Challenges and Solutions for the Latinx Population to Effectively Participate in Clinical Trials

Guidelines by the National Institutes of Health in 1994 mandated the inclusion of minority participants in clinical research. Despite these efforts, there is still inadequate representation of Latinx groups in U.S. clinical trials, which results in inequitable distribution of the risks and benefits of research participation and reduces the generalizability of trial results. 

Insightful solutions to fill the gap are suggested in this article

By Karen Mancera Cuevas MS, MPH, CHES

Associate Director, Research Projects at Northwestern University, Feinberg School of Medicine, Chicago USA

Challenges and Solutions for the Latinx Population to Effectively Participate in Clinical Trials


In the past decades, as the first-generation Latinx population has become more acclimated to the U.S. medical system, there has been ongoing interest in how to effectively engage the multi-faceted population comprised of a variety of nationalities, cultures, traditions, and dialects into clinical trials. Inclusion in clinical trials is important as Latinx are largely underrepresented in ongoing recruitment and retention efforts 1 in both academic and pharmaceutical studies. Guidelines published by the National Institutes of Health in 1994 mandated the inclusion of minority participants in clinical research 2. Despite these efforts, there is still inadequate representation of racial/ethnic groups in clinical trials, which results in inequitable distribution of the risks and benefits of research participation and reduces the generalizability of trial results 3. This is because the purpose of clinical trial research is to examine new ways to treat, prevent, and diagnose diseases or conditions 4.

Providers in many traditional clinical settings have limited time, resources, or personnel to effectively engage interested Latinx patients into studies 5. Although these factors exist, the role of trust with providers is critical for Latinx patients to participate in clinical trial research 6 that must be leveraged with added organizational infrastructure to facilitate participation. Patients who are less educated may not feel comfortable or even feel empowered to advocate for their interest in clinical research 7, understand the topic 8, or may even express fear of participation9.  Latinx participants need to find meaning in the relationship and proper accommodations such as scheduling mutually convenient times around work schedules and providing meaningful incentives are critical 10 in addressing cultural salient participant behavior. Increasing Latinx providers and advocates 1 are also integral to recruitment efforts and include having providers devote more time with study patients which may ultimately impact feelings of altruism as a motivator for participation 1.  Moreover, integration of clinical research within the clinic, as part of a patients overall health care plan, is usually absent or a final alternative therapy.  Earlier consideration of applicable clinical trials could provide the under resourced Latinx community with access to diagnostic procedures and therapies, which are usually cost prohibitive.

Solutions include addressing low literacy efforts and developing educational materials that effectively engage the intended Latinx audiences in the language of origin. As voiced in a study of Latino clinical trial participants, “If the message is going to be translated from English to Spanish, you have to be sure to choose the right words.” 1 Examples include language-congruent care, that influences behaviors, attitudes, and policies in clinical trial recruitment and is a key element in dissemination of awareness with Latinx patients 11. The educational method most applicable are audiovisual materials that offer advantages to Latinx populations in that they have been shown to have high rates of acceptability 12 over group or individual education sessions 13. Additionally, clinical trial studies indicate that health education materials, particularly those with a focus on promoting behavior change, are more successful when “transcreated” and available to the target population in their native language 14 where the text is not merely translated into another language; but it is reconstructed to meet the health literacy and informational needs of the target audience in a manner that is culturally appropriate 15.

Patient-centered trial designs16 incorporating Latinx centered solutions to address participant burden are necessary to promote increased trial participation. Measures include reduction of extra procedures, explanation of cost, and education to resolve negative perceptions of clinical trials and medical expertise5. Assurance from clinical trial recruitment staff should include the message that immigration status will not be documented1. The role of patient navigators has also been welcomed by Latinx participants as a way to overcome barriers although, findings have yielded greater application through clinical trial retention measures rather than recruitment efforts although navigated participants have demonstrated higher overall retention rates 17. Additionally, partnership with selected faith-based community-based organizations may increase participation rates with selected Latinx population groups (i.e. older adults) 8. Although recommendations are provided, health disparities outcomes among Latinx clinical trial patients will continue as long as therapies are not tested equally in targeted communities. This inequity needs to be properly addressed for future measures to be adapted in Latinx communities that will benefit from participation.



  1. Ford, M., Siminoff, L., Pickelsimer, E., Mainous, A., Smith, D., Diaz, VA, Soderstrom, L., Jefferson, M., Tilley, B., 2013 Unequal Burden of Disease, Unequal Participation in Clinical Trials: Solutions from African American and Latino Community Members. Health Social Work, 38 (10), 29-38.
  2. National Institutes of Health. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Available at: Published 1994. Accessed May 19, 2018.
  3. Pinsky, P., Ford, M., Gamito, E., Higgins, D., Jenkins, V., Lamerato L., Tenorio, S., Marcus, P., Gohagan, J.,.2008 Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Journal of the National Medical Association, 100(3), 291–298.
  4. Toledo, L., McLellan-Lemal, E., Arreola, S., Campbell, C., Sutton, M., 2014, African-American and Hispanic perceptions of HIV vaccine clinical research: a qualitative study. American Journal of Health Promotion, 29 (2), e82-90.
  5. Grunfeld , E., Zitzelsberger, L., Coristine, M., Aspelund, F., 2009 Barriers and facilitators to enrollment in cancer clinical trials: Qualitative study of the perspectives of clinical research associates. Cancer, 95:1577–1583.
  6. Ford, M., Alford, S., Britton, D., McClary, B., Gordon H., 2007 Factors influencing perceptions of breast cancer genetic counseling among women in an urban health care system. Journal of Genetic Counseling, 16:735–753.
  7. Ford, M., Wahlquist, A., Ridgeway, C., Streets, J., Mitchum, K., Harper, R. Jr., 2011, Evaluating an intervention to increase cancer knowledge in racially diverse communities in South Carolina. Patient Education and Counseling, 83:256–280.
  8. Moreno, G., Mangione, C., Meza, C., Kwon, I., Seeman, T., Trejo, L., Moore, M., Sarkisian, C, 2015, Perceptions from Latino and African American Older Adults about Biological Markers in Research, 25 (3), 355-362.
  9. Giuliano, A., Mokuau, N., Hughes, C., Tortolero-Luna, G., Risendal, B., Ho, R.,2000 Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Annals of Epidemiology, 10(Suppl. 8):S22.
  10. Gonzalez, E., Gardner, E., Murasko, D., 2007 Recruitment and retention of older adults in influenza immunization study. Journal of Cultural Diversity, 14:81–87.
  11. O’Brien, R., Kosoko-Lasaki, O., Cook, C., Kissell, J., Peak, F., Williams, E., 2006 Self-assessment of cultural attitudes and competence of clinical investigators to enhance recruitment and participation of minority populations in research. Journal of the National Medical Association, 98:674–682.
  12. Albrecht, T., Ruckdeschel, J., Riddle, D., Blanchard, C., Penner, L., Coovert, M., 2003. Communication and consumer decision making about cancer clinical trials. Patient Education and Counseling. 50(1):39–42.
  13. Hutchison, C., Cowan, C., McMahon, T., Paul, J., 2007 A randomised controlled study of an audiovisual patient information intervention on informed consent and recruitment to cancer clinical trials. British Journal of Cancer, 97:705–711.
  14. Solomon, F., Eberl-Lefko, A., Michaels, M., Macario, E., Tesauro, G., Rowland, J, 2005 Development of a linguistically and culturally appropriate booklet for Latino cancer survivors: lessons learned. Health Promotion Practice. 6:405.
  15. Quinn, G., Hauser, K., Bell-Ellison, B., Rodriguez, N., Frias J., 2006. Promoting pre-conceptual use of folic acid to Hispanic women: A social marketing approach. Maternal Child Health Journal. 10:403–412.
  16. Mullins, C., Vandigo, J., Zheng, Z., Wicks, P., 2014 Patient-Centeredness in the Design of Clinical Trials. Value in Health. 17(4):471-475.
  17. Guadagnolo, B., Petereit, D., Helbig, P., Koop, D., Kussman, P., Dunn, E., Patnaik A., 2009 Involving American Indians and medically underserved rural populations in cancer clinical trials. Clinical Trials. 6:610–617.



Health Breaking News: Link 289

Health Breaking News Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

Health Breaking News: Link 289


What you need to know about the 71st WHA 

Global Health Policymakers Take Action To Improve Access To Assistive Products 

EU Set To Downgrade Political Ambition On Health Of EU Citizens 

European Congress 2018 in Kassel A different Europe is possible! Democratic, peaceful, ecological, feminist, based on solidarity. University of Kassel 5th – 7th October 

Transparency TOSSD overboard? Two major flaws with the proposed new measure of international resource flows 

WEMOS: PAYING FOR UNIVERSAL HEALTH COVERAGE The need to pool financial resources 

LSHTM: Next Generation report 2018-2022 

China-led development bank drives tech push among BRICS nations 

The next forum for unraveling FDA off-label marketing rules: State and federal legislatures 

Fake Medicines To Be Discussed On Side Of WTO TRIPS Council Next Week 

South Africa Approves New IP Policy, With Guidance From UN Agencies 

New South African IP Policy Text Now Available 

WTO TRIPS Council: Submission of China and South Africa on Promoting Public Health Through Competition Law and Policy 

Ebola situation reports: Democratic Republic of the Congo  

It look as though Ebola lessons have been learned 

Vaccines Alone Won’t Beat Ebola 

Ebola: Fear, suspicion, and anger along Congo’s river of worry 

Cholera ‘third wave’ threatens Yemen  

Mikhail Golichenko: “HIV Epidemic in Russia is an Epidemic of Powerlessness” 

Afghanistan: Big plan, small details – how microplans ensure we can end polio 

Preventing an AMR public health crisis: it’s time to stop preaching to the converted 

Antimicrobial Resistance: Getting the balance right 

How to combat NCDs? Take a sector-wide approach 

WHO makes U-turn in taxation of sugary drinks 

EPHA: Study I Policy Principles for Sustainable Food Systems in Europe 

Human Rights Reader 449 

Away from tallying the injured and mourning the killed: The Peril of ignoring public health services in Gaza 

Save the Children report says 1.2bn children at risk  

Healthy buildings, healthier people 

Social Determinants Of Health: A Public Health Concept In Conflict  

Skewed Priorities? How Philanthropy Has Shaped Debates Over Climate Change 

How a Foundation’s Focus on Cities Made it a Leader in a Changing Environmental Movement 

World Environment Day Highlights Deadly Cost of Plastic